Hallervorden-Spatz Syndrome (PKAN)

S. J. Hayflick

doi:10.1016/B978-0-12-374105-9.00124-6

Hallervorden-Spatz Syndrome (PKAN)

S. J. Hayflick

Molecular and Medical Genetics

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Hallervorden-Spatz syndrome is a genetic disorder associated with brain iron accumulation. The features include dystonia, dysarthria, pigmentary retinopathy, and characteristic MRI changes. Mutations in the gene encoding pantothenate kinase 2 underlie this disorder, now referred to as pantothenate kinase-associated neurodegeneration or PKAN. Although treatment remains palliative, rational therapeutics are being explored.

Original language	English (US)
Title of host publication	Encyclopedia of Movement Disorders, Three-Volume Set
Publisher	Elsevier
Pages	V2-1-V2-3
ISBN (Electronic)	9780123741059
DOIs	https://doi.org/10.1016/B978-0-12-374105-9.00124-6
State	Published - Jan 1 2010

Keywords

Axonal spheroids
Brain iron
Coenzyme A
Globus pallidus
Hallervorden-Spatz syndrome
PANK2
Pantothenate kinase-associated neurodegeneration (PKAN)

ASJC Scopus subject areas

General Medicine
General Neuroscience

Access to Document

10.1016/B978-0-12-374105-9.00124-6

Cite this

@inbook{dfdedab7b6ea453fb36397dba3499656,

title = "Hallervorden-Spatz Syndrome (PKAN)",

abstract = "Hallervorden-Spatz syndrome is a genetic disorder associated with brain iron accumulation. The features include dystonia, dysarthria, pigmentary retinopathy, and characteristic MRI changes. Mutations in the gene encoding pantothenate kinase 2 underlie this disorder, now referred to as pantothenate kinase-associated neurodegeneration or PKAN. Although treatment remains palliative, rational therapeutics are being explored.",

keywords = "Axonal spheroids, Brain iron, Coenzyme A, Globus pallidus, Hallervorden-Spatz syndrome, PANK2, Pantothenate kinase-associated neurodegeneration (PKAN)",

author = "Hayflick, {S. J.}",

year = "2010",

month = jan,

day = "1",

doi = "10.1016/B978-0-12-374105-9.00124-6",

language = "English (US)",

pages = "V2--1--V2--3",

booktitle = "Encyclopedia of Movement Disorders, Three-Volume Set",

publisher = "Elsevier",

}

TY - CHAP

T1 - Hallervorden-Spatz Syndrome (PKAN)

AU - Hayflick, S. J.

PY - 2010/1/1

Y1 - 2010/1/1

N2 - Hallervorden-Spatz syndrome is a genetic disorder associated with brain iron accumulation. The features include dystonia, dysarthria, pigmentary retinopathy, and characteristic MRI changes. Mutations in the gene encoding pantothenate kinase 2 underlie this disorder, now referred to as pantothenate kinase-associated neurodegeneration or PKAN. Although treatment remains palliative, rational therapeutics are being explored.

AB - Hallervorden-Spatz syndrome is a genetic disorder associated with brain iron accumulation. The features include dystonia, dysarthria, pigmentary retinopathy, and characteristic MRI changes. Mutations in the gene encoding pantothenate kinase 2 underlie this disorder, now referred to as pantothenate kinase-associated neurodegeneration or PKAN. Although treatment remains palliative, rational therapeutics are being explored.

KW - Axonal spheroids

KW - Brain iron

KW - Coenzyme A

KW - Globus pallidus

KW - Hallervorden-Spatz syndrome

KW - PANK2

KW - Pantothenate kinase-associated neurodegeneration (PKAN)

UR - http://www.scopus.com/inward/record.url?scp=85184557410&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85184557410&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-374105-9.00124-6

DO - 10.1016/B978-0-12-374105-9.00124-6

M3 - Chapter

AN - SCOPUS:85184557410

SP - V2-1-V2-3

BT - Encyclopedia of Movement Disorders, Three-Volume Set

PB - Elsevier

ER -

Hallervorden-Spatz Syndrome (PKAN)

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this